During the past decade, Medstar Heart and Vascular Institute conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medstar Heart and Vascular Institute" #1 sponsor was "Amgen" with 1 trials, followed by "Boston Scientific Corporation" with 1 trials sponsored, "Cardiol Therapeutics Inc." with 1 trials sponsored, "Medtronic Cardiovascular" with 1 trials sponsored and "On-X Life Technologies, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medstar Heart and Vascular Institute" #1 collaborator was "Acelis Connected Health" with 1 trials as a collaborator, "Avania" with 1 trials as a collaborator, "Clinipace Worldwide" with 1 trials as a collaborator and "WCG IRB" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Medstar Heart and Vascular Institute" are "AAA" (1 trials), "Abdominal Aortic Aneurysm" (1 trials), "Acute Myocarditis" (1 trials), "Aortic Valve Stenosis" (1 trials) and "Combined Pulmonary Fibrosis and Emphysema" (1 trials). Many other conditions were trialed in "Medstar Heart and Vascular Institute" in a lesser frequency.

Most popular intervention types in "Medstar Heart and Vascular Institute" are "Device" (4 trials), "Drug" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "CardiolRx" (1 trials), "Endovascular aneurysm repair (EVAR)" (1 trials), "Endurant Evo AAA Stent Graft System" (1 trials), "Evolocumab" (1 trials) and "Inhaled Treprostinil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medstar Heart and Vascular Institute" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Medstar Heart and Vascular Institute". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Medstar Heart and Vascular Institute, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Medstar Heart and Vascular Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".